T. Rowe Price Associates »

Ambrx Biopharma shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Ambrx Biopharma shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Ambrx Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Ambrx Biopharma held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ambrx Biopharma by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2023-12-31 $15M 1.1M 14.24

More positions owned by T. Rowe Price Associates

Microsoft Corp Comm Stk (MSFT)
Nvidia Corporation Comm Stk (NVDA)
Apple Comm Stk (AAPL)
Amazon Comm Stk (AMZN)
Meta Platforms Comm Stk (META)
Eli Lilly & Co Comm Stk (LLY)
Alphabet Comm Stk (GOOGL)
Alphabet Comm Stk (GOOG)
Unitedhealth Group Comm Stk (UNH)
Visa Comm Stk (V)
Mastercard Incorporated Comm Stk (MA)
Fiserv Comm Stk (FI)
Netflix Comm Stk (NFLX)
Intuitive Surgical Comm Stk (ISRG)
Servicenow Comm Stk (NOW)

View all positions for T. Rowe Price Associates

Top funds holding Ambrx Biopharma

Federated Investors
Alliancebernstein
Altitude Crest Partners
Virtu Financial

View all funds holding Ambrx Biopharma